1. Home
  2. SNAL vs CRVO Comparison

SNAL vs CRVO Comparison

Compare SNAL & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Snail Inc.

SNAL

Snail Inc.

SELL

Current Price

$2.34

Market Cap

21.2M

Sector

Technology

ML Signal

SELL

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$1.44

Market Cap

21.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNAL
CRVO
Founded
2000
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
21.5M
IPO Year
2022
2011

Fundamental Metrics

Financial Performance
Metric
SNAL
CRVO
Price
$2.34
$1.44
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $15.20
AVG Volume (30 Days)
150.0K
★ 917.1K
Earning Date
11-12-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 120.00
N/A
EPS
★ N/A
N/A
Revenue
★ $81,225,622.00
$4,006,510.00
Revenue This Year
$25.62
N/A
Revenue Next Year
$7.81
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.59
$1.27
52 Week High
$21.60
$10.00

Technical Indicators

Market Signals
Indicator
SNAL
CRVO
Relative Strength Index (RSI) 52.03 35.79
Support Level $1.92 $1.27
Resistance Level $2.63 $2.20
Average True Range (ATR) 0.31 0.24
MACD 0.03 0.01
Stochastic Oscillator 46.55 17.20

Price Performance

Historical Comparison
SNAL
CRVO

About SNAL Snail Inc.

Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States. The Company has one operating and reportable segment. The company operates in the USA, the UK and Other Countries.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: